PHI with Multiple hereditary exostoses
How does this condition affect your private health insurance?
Kartilaginäre Exostosenkrankheit, also known as Multiple Hereditary Exostoses (MHE), is an autosomal dominant genetic disorder characterized by the development of multiple benign cartilage-capped bony growths called osteochondromas. These tumors typically arise from the growth plates of long bones, often causing pain, deformities, limb length discrepancies, and nerve compression. While benign, there is a small (2-5%) risk of malignant transformation to chondrosarcoma. MHE is caused by mutations in the EXT1 or EXT2 genes, affecting skeletal development and function, impacting quality of life.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Growths typically appear in early childhood and progressively develop over months to years.
Duration of Illness (Lifetime)
Chronic, lifelong condition; exostoses develop during growth and persist, with potential for new lesions or complications at any age.
Cost of Treatment (Initial)
Highly variable; ranges from low (monitoring) to moderate-high (initial surgical removal of symptomatic exostosis, e.g., ","5,000-","20,000).
Cost of Treatment (Lifetime)
High; often involves multiple surgeries, ongoing orthopedic monitoring, physiotherapy, and imaging throughout life, potentially exceeding ","100,000.
Mortality Rate
Extremely low; direct mortality is rare, primarily associated with advanced malignant transformation (chondrosarcoma) or severe surgical complications.
Risk of Secondary Damages
High; common complications include pain, restricted joint mobility, limb length discrepancies, angular deformities, nerve/vessel compression, and a 2-5% risk of malignant transformation to chondrosarcoma.
Probability of Full Recovery
Low to none for the underlying genetic condition. Surgical intervention can resolve specific localized symptoms, but the propensity for new or recurring exostoses and related issues persists.
Underlying Disease Risk
MHE itself is the primary genetic disease. It causes a high probability of specific complications rather than other underlying diseases, such as limb length discrepancies, angular deformities, nerve compression, and chondrosarcoma development.